CLOSE X

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE11246.25193.05 (+1.75 %)
PREV CLOSE ( ) 11053.20
OPEN PRICE ( ) 11199.40
BID PRICE (QTY) 11226.90 (5)
OFFER PRICE (QTY) 11246.25 (4)
VOLUME 1438
TODAY'S LOW / HIGH ( )11031.45 11321.25
52 WK LOW / HIGH ( )5557 18089.55
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 07-01 1984
Management Info
Davuluri Rama Mohan Rao - Chairman Davuluri Saharsh Rao - Managing Director
Registered Office

Address 11th Floor (5th Office Level),Phoenix I V Y Building, Plot No.573 A- I I I,Road No. 82, Jubilee Hills,
Hyderabad,
Telangana-500033

Phone 040-67611600 / 67611700

Email neuland@neulandlabs.com

Website www.neulandlabs.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
16May Neuland Laboratories informs about ne
Pursuant to Regulation 47 of the Securities and Exchange Board of India..
16May Neuland Laboratories informs about ne
Pursuant to Regulation 47 of the Securities and Exchange Board of India..
16May Neuland Laboratories approves dividend
Neuland Laboratories has informed that the Board of Directors at their m..
05May Neuland Laboratories informs about ea
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
03May USFDA inspects Neuland Laboratories’ U
The United States Food and Drug Administration (USFDA) has inspected Neu..
Financials
Rs. in Millions
QTR Mar 25 ANNUAL 25
Net Profit277.342594.26
Gross Profit 389.82 3453.74
Operating Profit 582.183428.08
Net Sales 3283.614768.37
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Divi's Lab (BSE)
 6639.35 (5.70%)
M.Cap ( in Cr)176717.12
Astrazeneca Pharma I (BSE)
 8019.55 (2.30%)
M.Cap ( in Cr)20018.88
Caplin Point Lab (BSE)
 2139.10 (6.26%)
M.Cap ( in Cr)16364.18
Alkem Laboratories (BSE)
 5345.95 (2.39%)
M.Cap ( in Cr)64171.73
Procter&Gamble Healt (BSE)
 5303.90 (2.20%)
M.Cap ( in Cr)8750.36
Shareholding Pattern
NON-INSTITUTION 33.84%
PROMOTERS 32.68%
MUTUAL FUNDS/UTI 7.43%
FI/BANKS/INSURANCE 0.96%
GOVERNMENT 0.4%
FII 0%

Badjate Stock & Shares Pvt. Ltd.
201, Mangalam Arcade,
Above Venus Book Centre, Dharampeth Extn. Nagpur - 440010 Maharashtra, India.

Advisory for Investors Complaints Data April 2025 Broking Complaints Data April 2025 DP

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal(https://scores.sebi.gov.in/)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341 / 57500000546632
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.